Monday , July 26 2021

Five major benefits from the acquisition of $ 5B Spark Therapeutics at Roche

Land starts with the two biggest messages: RHHBY $ 5 billion of Spark Therapeutics (ONCE) swallowing means that big pharmaceutical companies are at full purchase, and that gene therapy, a long-awaited approach to hereditary illness, has made great time .

The Wall Street Journal reported on Saturday that Roche is in talks to buy Spark at 150% the premium on market capitalization of smaller companies on Friday. On Monday morning, the two companies announced that Roche would buy Spark for $ 4.8 billion, or $ 114.50 a share. Here are five things to keep in mind about this news for anyone interested in the biotech sector.

Unlock this article by subscribing to STAT Plus and enjoying your first 30 days for free!


Source link